Re: trial no 2

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: trial no 2

in response to

trial no 2

Hartland

posted on Oct 30, 2016 04:32PM

Trial one started dosing June 15, 2016, so it is nearing completion of month five . I don't recall management saying that trial two would start six months after the first trial started. But if that is the case , we have another month and change to go . We are overdue for an update and will hopefully get one before the December AGM .